Join the Influenza Prophylaxis group to help and get support from people like you.
Influenza Prophylaxis News
Related terms: Flu Prevention
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
THURSDAY, Sept. 12, 2024 – A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the p...
Universal Flu Vaccine Blocks Infection in Mice
THURSDAY, Aug. 22, 2024 – A universal flu vaccine that would protect against all influenza strains – and that people might not need to take every year – could be close at hand, researchers report....
Some Americans Lost Trust in Medical Profession During Pandemic
WEDNESDAY, July 31, 2024 – The number of people who trust doctors dropped steeply during the COVID-19 pandemic, a new study says. Worse, those who lost their faith in medicine are less likely to get...
Preparedness for HPAI A(H5N1) Virus Varies Across Jurisdictions
TUESDAY, May 21, 2024 – Variation is seen in preparedness and response to highly pathogenic avian influenza (HPAI) A(H5N1) viruses, according to a research letter published online May 21 in the...
No Elevated Risk for Stroke Seen After COVID-19 Bivalent Vaccine Receipt
WEDNESDAY, March 20, 2024 – For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent...
Birth Month Linked to Timing of Influenza Vaccination in Young Children
THURSDAY, Feb. 22, 2024 – For young children, birth month is associated with timing of influenza vaccination, according to a study published online Feb. 21 in The BMJ. Christopher M. Worsham, M.D.,...
Flu Activity Slows Down, But Season Far From Over: CDC
MONDAY, Jan. 15, 2024 – Following weeks of increases in flu activity, the latest U.S. government data shows "a single-week decrease" for the first time in months. But health officials warn that the...
Could Antibody Discovery Lead to Better Flu Vaccines?
FRIDAY, Dec. 29, 2023 – Researchers appear to have discovered a new weapon in the war on a particularly difficult foe. They have identified a previously unrecognized class of antibodies that seem to...
Most U.S. Parents Plan to Vaccinate Kids Against Flu, RSV: Survey
MONDAY, Dec. 18, 2023 – Most parents plan to have their kids vaccinated against influenza and respiratory syncytial virus (RSV), even as COVID-19 vaccine acceptance flags, a new poll finds. Seven in...
Too Few Americans Are Getting Vaccinated for Flu, COVID & RSV, CDC Warns
FRIDAY, Dec. 15, 2023 – Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned...
Flu Shots Up for Children in States With Vaccine Mandate
TUESDAY, Oct. 10, 2023 – Children living in states with a vaccine mandate during the 2020 to 2021 influenza season had a higher predicted probability of receiving an influenza vaccine, according to...
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
THURSDAY, Oct. 5, 2023 – Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19. In interim findings...
Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person
South San Francisco, CA – November 23, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ – The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6...